Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,912 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
Ashida T, Kohgo Y, Munakata A, Noguchi M, Iizuka B, Endo Y, Hanai H, Yoshikawa T, Matsumoto T, Aoyama N, Matsui T, Mitsuyama K, Hibi T. Ashida T, et al. Among authors: yoshikawa t. Transfus Apher Sci. 2011 Apr;44(2):113-7. doi: 10.1016/j.transci.2011.01.001. Transfus Apher Sci. 2011. PMID: 21402309 Clinical Trial.
Factors associated with adverse events and three-year survival following endoscopic submucosal dissection for early gastric cancer in patients aged 85 years or older.
Yoshikawa T, Utsumi T, Inoue T, Agatsuma N, Tanaka Y, Yabuuchi Y, Araki O, Murai K, Tochio T, Kumagai K, Iwagami H, Masui Y, Kashima H, Setoyama T, Konishi T, Morisawa T, Kitami M, Nishioka Y, Kanda N, Matsuura K, Fujiwara M, Shio S, Tanaka J, Marui S, Nishikawa Y, Nakanishi Y, Yazumi S, Seno H; KONOE Project. Yoshikawa T, et al. Surg Endosc. 2025 Nov 7. doi: 10.1007/s00464-025-12361-5. Online ahead of print. Surg Endosc. 2025. PMID: 41203902
Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapy.
Zhao X, Hao Q, Alsina M, Acosta D, Castet F, Terán E, Cano KV, Saurí T, Macías I, Yoshikawa T, Castro S, Shoji H, Lordick F, Shen Z, Tian TV, Macarulla T. Zhao X, et al. Among authors: yoshikawa t. Cancer Treat Rev. 2025 Oct 24;141:103041. doi: 10.1016/j.ctrv.2025.103041. Online ahead of print. Cancer Treat Rev. 2025. PMID: 41187568 Review.
4,912 results